Masahisa Kitagawa
President chez Teikoku Pharma UK Ltd.
Profil
Masahisa Kitagawa co-founded Teikoku Pharma USA June, 1997 and currently serves as President and Chief Executive Officer.
He served as Senior Director of the International Division, Managing Director for Research and Development and a Director for Teikoku Seiyaku Co. Mr. Kitagawa began his career at Daiwa Chemical.
He received a Bachelor's degree from the University of Tokyo.
Postes actifs de Masahisa Kitagawa
| Sociétés | Poste | Début |
|---|---|---|
Teikoku Pharma UK Ltd.
 Teikoku Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Pharma UK Ltd. manufactures pharmaceuticals. The company is engaged in finding and developing pharmaceuticals in Europe. It is a subsidiary of Teikoku Seikyaku Co. The company also supports the development of Lidoderm, a local anesthetic plaster for the treatment of post herpetic neuralgia. It was founded on February 28, 2001 and is headquartered in London, UK | President | - |
Teikoku Seiyaku Co. Ltd.
 Teikoku Seiyaku Co. Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan | Directeur/Membre du Conseil | 15/11/2013 |
Anciens postes connus de Masahisa Kitagawa
| Sociétés | Poste | Fin |
|---|---|---|
| Daiwa Chemical Industries Co., Ltd. | Corporate Officer/Principal | - |
Teikoku Pharma USA, Inc.
 Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | Directeur Général | - |
Formation de Masahisa Kitagawa
| University of Tokyo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Teikoku Pharma USA, Inc.
Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | Health Technology |
Teikoku Pharma UK Ltd.
Teikoku Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Pharma UK Ltd. manufactures pharmaceuticals. The company is engaged in finding and developing pharmaceuticals in Europe. It is a subsidiary of Teikoku Seikyaku Co. The company also supports the development of Lidoderm, a local anesthetic plaster for the treatment of post herpetic neuralgia. It was founded on February 28, 2001 and is headquartered in London, UK | Health Technology |
Teikoku Seiyaku Co. Ltd.
Teikoku Seiyaku Co. Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan | Health Technology |
| Daiwa Chemical Industries Co., Ltd. |
